These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36839990)

  • 1. Sustained and Targeted Delivery of Self-Assembled Doxorubicin Nonapeptides Using pH-Responsive Hydrogels for Osteosarcoma Chemotherapy.
    Zhu J; Gao R; Wang Z; Cheng Z; Xu Z; Liu Z; Wu Y; Wang M; Zhang Y
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
    Qu J; Zhao X; Ma PX; Guo B
    Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Chemotherapy for Breast Cancer Using an Intelligent Doxorubicin-Loaded Hexapeptide Hydrogel.
    Luo S; Zhu Y; Li Y; Chen L; Lv S; Zhang Y; Ge L; Zhou W
    J Biomed Nanotechnol; 2020 Jun; 16(6):842-852. PubMed ID: 33187580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
    Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
    Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable pH and redox dual responsive hydrogels based on self-assembled peptides for anti-tumor drug delivery.
    Zhu Y; Wang L; Li Y; Huang Z; Luo S; He Y; Han H; Raza F; Wu J; Ge L
    Biomater Sci; 2020 Oct; 8(19):5415-5426. PubMed ID: 32996920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
    Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable and pH-Responsive Silk Nanofiber Hydrogels for Sustained Anticancer Drug Delivery.
    Wu H; Liu S; Xiao L; Dong X; Lu Q; Kaplan DL
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17118-26. PubMed ID: 27315327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate bonding strategy for molecularly imprinted hydrogels: toward pH-responsive doxorubicin delivery.
    Zhang Q; Zhang L; Wang P; Du S
    J Pharm Sci; 2014 Feb; 103(2):643-51. PubMed ID: 24395706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable and self-healing polysaccharide-based hydrogel for pH-responsive drug release.
    Qian C; Zhang T; Gravesande J; Baysah C; Song X; Xing J
    Int J Biol Macromol; 2019 Feb; 123():140-148. PubMed ID: 30419332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy.
    Zeng Y; Zhang C; Du D; Li Y; Sun L; Han Y; He X; Dai J; Shi L
    Acta Biomater; 2022 Jun; 145():43-51. PubMed ID: 35398545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multifunctional NCQDs-based injectable self-crosslinking and in situ forming hydrogel as an innovative stimuli responsive smart drug delivery system for cancer therapy.
    Türk S; Altınsoy I; Efe GÇ; Ipek M; Özacar M; Bindal C
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111829. PubMed ID: 33579469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
    Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment.
    Liu Y; Ran Y; Ge Y; Raza F; Li S; Zafar H; Wu Y; Paiva-Santos AC; Yu C; Sun M; Zhu Y; Li F
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable, NIR/pH-Responsive Nanocomposite Hydrogel as Long-Acting Implant for Chemophotothermal Synergistic Cancer Therapy.
    Xu X; Huang Z; Huang Z; Zhang X; He S; Sun X; Shen Y; Yan M; Zhao C
    ACS Appl Mater Interfaces; 2017 Jun; 9(24):20361-20375. PubMed ID: 28532154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyoxylic Hydrazone Linkage-Based PEG Hydrogels for Covalent Entrapment and Controlled Delivery of Doxorubicin.
    Sharma PK; Singh Y
    Biomacromolecules; 2019 Jun; 20(6):2174-2184. PubMed ID: 31021601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled biocompatible heparin-based supramolecular hydrogel for doxorubicin delivery.
    Zhou Q; Li C; Guo J; Jiang W; Zhu Y; Mao W; Li L
    Carbohydr Res; 2022 Jan; 511():108464. PubMed ID: 34741880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable and Biodegradable pH-Responsive Hydrogels for Localized and Sustained Treatment of Human Fibrosarcoma.
    Li L; Gu J; Zhang J; Xie Z; Lu Y; Shen L; Dong Q; Wang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(15):8033-40. PubMed ID: 25838258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanogel-Incorporated Injectable Hydrogel for Synergistic Therapy Based on Sequential Local Delivery of Combretastatin-A4 Phosphate (CA4P) and Doxorubicin (DOX).
    Yang WJ; Zhou P; Liang L; Cao Y; Qiao J; Li X; Teng Z; Wang L
    ACS Appl Mater Interfaces; 2018 Jun; 10(22):18560-18573. PubMed ID: 29767951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.